関連レポート

ワクチンの世界市場：疾患別、技術別2028年予測

出版元：Transparency Market Research  出版元について

発行年：2024年1月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 222ページになります。

商品コード：TMR199

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

アレルゲン免疫療法の世界市場規模は2022年で24億ドル、2031年に56億ドル、市場の平均年成長率は9.6%に拡大すると予想されています。

当レポートでは、アレルゲン免疫療法の市場予測-2031年、各種セグメント別市場分析(治療別、アレルギータイプ別、国地域別、等)、業界構造分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■アレルゲン免疫療法の世界市場予測2017-2031年
・市場規模(US$)

■治療別、市場-2031年
皮下免疫療法（SCIT）
舌下免疫療法（SLIT）
※(市場規模US$)

■アレルギータイプ別、市場-2031年
アレルギー性鼻炎
喘息
食物アレルギー
毒物アレルギー
その他
※(市場規模US$)

■販売経路別、市場-2031年
病院薬局
小売薬局/ドラッグストア
オンライン薬局
※(市場規模US$)

■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス（促進要因、障壁、機会）
業界構造分析
COVID-19の影響分析
競合状況
市場シェア分析

■アレルゲン免疫療法の主要企業プロフィール動向
ALK-Abello A/S
Allergy Therapeutics
Stallergenes Greer
HAL Allergy Group
DBV Technologies
Merck KGaA
Aimmune Therapeutics
Carcassia
Anergis
Biomay AG
（全222頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Allergy Immunotherapy Market Analysis and Forecast, 2017–2031
4.5. Porter’s Five Force Analysis

5. Key Insights
5.1. COVID-19 Pandemic Impact on Industry

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment, 2017–2031
6.3.1. Subcutaneous Immunotherapy (SCIT)
6.3.2. Sublingual Immunotherapy (SLIT)
6.4. Market Attractiveness Analysis, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Allergy Type, 2017–2031
7.3.1. Allergic Rhinitis
7.3.2. Asthma
7.3.3. Food Allergy
7.3.4. Venom Allergy
7.3.5. Others
7.4. Market Attractiveness Analysis, By Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies & Drug Stores
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, By Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment, 2017–2031
10.2.1. Subcutaneous Immunotherapy (SCIT)
10.2.2. Sublingual Immunotherapy (SLIT)
10.3. Market Value Forecast, by Allergy Type, 2017–2031
10.3.1. Allergic Rhinitis
10.3.2. Asthma
10.3.3. Food Allergy
10.3.4. Venom Allergy
10.3.5. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies & Drug Stores
10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Allergy Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Allergy Immunotherapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment, 2017–2031
11.2.1. Subcutaneous Immunotherapy (SCIT)
11.2.2. Sublingual Immunotherapy (SLIT)
11.3. Market Value Forecast, by Allergy Type, 2017–2031
11.3.1. Allergic Rhinitis
11.3.2. Asthma
11.3.3. Food Allergy
11.3.4. Venom Allergy
11.3.5. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2031
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies & Drug Stores
11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Allergy Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment, 2017–2031
12.2.1. Subcutaneous Immunotherapy (SCIT)
12.2.2. Sublingual Immunotherapy (SLIT)
12.3. Market Value Forecast, by Allergy Type, 2017–2031
12.3.1. Allergic Rhinitis
12.3.2. Asthma
12.3.3. Food Allergy
12.3.4. Venom Allergy
12.3.5. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2031
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies & Drug Stores
12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Allergy Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Allergy Immunotherapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment, 2017–2031
13.2.1. Subcutaneous Immunotherapy (SCIT)
13.2.2. Sublingual Immunotherapy (SLIT)
13.3. Market Value Forecast, by Allergy Type, 2017–2031
13.3.1. Allergic Rhinitis
13.3.2. Asthma
13.3.3. Food Allergy
13.3.4. Venom Allergy
13.3.5. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2031
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies & Drug Stores
13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Allergy Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment, 2017–2031
14.2.1. Subcutaneous Immunotherapy (SCIT)
14.2.2. Sublingual Immunotherapy (SLIT)
14.3. Market Value Forecast, by Allergy Type, 2017–2031
14.3.1. Allergic Rhinitis
14.3.2. Asthma
14.3.3. Food Allergy
14.3.4. Venom Allergy
14.3.5. Others
14.4. Market Value Forecast, by Distribution Channel, 2017–2031
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies & Drug Stores
14.4.3. Online Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment
14.6.2. By Allergy Type

15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. ALK-Abello A/S
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Treatment Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Allergy Therapeutics
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Treatment Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Stallergenes Greer
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Treatment Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. HAL Allergy Group
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Treatment Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. DBV Technologies
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Treatment Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Merck KGaA
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Treatment Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Aimmune Therapeutics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Treatment Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Carcassia
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Treatment Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Anergis
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Treatment Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Biomay AG
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Treatment Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 02: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 07: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 08: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 11: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 12: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 13: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 15: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 16: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 19: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 20: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 23: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 24: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Allergy Immunotherapy Market Value Share, by Treatment, 2022

Figure 03: Global Allergy Immunotherapy Market Value Share, by Distribution Channel, 2022

Figure 04: Global Allergy Immunotherapy Market Value Share, by Region, 2022

Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 06: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Silicone, 2017–2031

Figure 08: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Polyolefins, 2017–2031

Figure 9: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 10: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Allergic Rhinitis, 2017–2031

Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn), Asthma, 2017–2031

Figure 13: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Food Allergy, 2017–2031

Figure 14: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Venom Allergy, 2017–2031

Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Others, 2017–2031

Figure 16: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 17: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031

Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Retail Pharmacies & Drug Stores, 2017–2031

Figure 20: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031

Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2022 and 2031

Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2023–2031

Figure 23: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 24: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2022 and 2031

Figure 25: North America Allergy Immunotherapy Market Attractiveness Analysis, by Country, 2023–2031

Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 30: North America Allergy Immunotherapy Market Value Share Analysis (US$ Mn), by Distribution Channel, 2017–2031

Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 32: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 33: Europe Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 34: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 35: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 36: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 37: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 38: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 39: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 40: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 41: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 43: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 50: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Latin America Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 52: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 53: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 54: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 55: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017–2031

Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 54: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 56: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 57: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 58: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 59: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 60: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 61: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017–2031

Figure 62: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 63: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 64: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

△ 一番上に戻る